Anika Therapeutics, Inc. (ANIK)
14.12
-0.13
(-0.91%)
USD |
NASDAQ |
Mar 06, 16:00
14.05
-0.07
(-0.50%)
After-Hours: 20:00
Anika Therapeutics Cash from Investing (TTM) : -0.401M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| BioCryst Pharmaceuticals, Inc. | -13.69M |
| Lantheus Holdings, Inc. | -627.17M |
| TELA Bio, Inc. | 0.464M |
| Plus Therapeutics, Inc. | 0.287M |
| BioStem Technologies, Inc. | -1.796M |